Corrigendum to "MeCP2 promotes gastric cancer progression through regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 signaling pathways" [EBioMedicine 16 (2017) 87-100]

EBioMedicine. 2023 May:91:104579. doi: 10.1016/j.ebiom.2023.104579. Epub 2023 Apr 21.
No abstract available

Publication types

  • Published Erratum